
Breakout Stocks: How to trade Biocon, RBL Bank & HDFC AMC that hit fresh 52-week high?
Sectoral Summary
Breakout Stocks
Analyst Call
Live Events
Biocon
ETMarkets.com
RBL Bank
ETMarkets.com
HDFC AMC
ETMarkets.com
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
Indian market closed flat with a positive bias on Wednesday. The BSE Sensex rose more than 60 points while the Nifty50 closed above 25200 levels.Sectorally, buying was seen in auto, FMCG, realty, and IT stocks while selling was seen in healthcare, capital goods and metal stocks.Stocks that hit fresh 52-week high include names like Biocon which rose more than 1%, RBL Bank rose 2% and HDFC AMC was up 1.3% on Wednesday.We spoke to an analyst on how one should look at these stocks for the next trading day, entirely from an educational point of view:Analyst: Sanket Thakar, CMT, Founder – Alpha Bot CapitalBiocon has faced rejection from the previous active supply zone for the fourth time now, acting as a strong resistance area. Ideally, for bulls, it is safer to enter after a breakout above the resistance at 425.RBL Bank, after a strong upside rally, has reached its previous supply zone, which can act as a profit-booking level for traders. The support levels below are at the trendline, at 262 and 245.HDFC AMC has broken out of an ascending triangle pattern on the hourly chart. The overall trend is bullish, with the nearest resistance at 5,453.(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
11 minutes ago
- Business Standard
India relatively safe amid trade uncertainty; remain overweight: JP Morgan
Besides India, Korea, Brazil, United Arab Emirates (UAE), Poland and Philippines are the other emerging markets (EMs) where JP Morgan has maintained an 'overweight' stance Puneet Wadhwa New Delhi Listen to This Article India remains a relatively safe-haven amid trade-related uncertainty, wrote analysts at JP Morgan in a recent note, and maintain an 'overweight' stance on Indian equities in this backdrop. Besides India, Korea, Brazil, United Arab Emirates (UAE), Poland and Philippines are the other emerging markets (EMs) where JP Morgan has maintained an 'overweight' stance. 'Falling inflation, enhanced system liquidity and lower borrowing is likely to boost growth. Timely demand stimulus and support to urban household balance sheet bodes well. Recovery in rural economy further aided by a favourable monsoon. India is a relative safe haven amid trade uncertainty. It is expected to have

Business Standard
11 minutes ago
- Business Standard
Rupee trades near one-month low despite tariff cheers; opens at 86.41/$
The Indian Rupee opened near the one-month low level on Wednesday as the US-Japan trade deal failed to lift sentiments in the country's forex market. The domestic currency opened 4 paise lower at 86.41 against the dollar on Wednesday, according to Bloomberg. The rupee has witnessed nearly 0.93 per cent depreciation in the current calendar year. On Tuesday, the rupee briefly recovered to 86.22 before slipping to a one-month low of 86.41 against the greenback. The Indian rupee, which had weakened to 86.42 in the previous session, is set to trade stronger, supported by optimism around the Japan trade deal that lifted sentiment across Asian markets, according to Anil Kumar Bhansali, head of treasury and executive director at Finrex Treasury Advisors LLP. Exporters are advised to hold off on booking, with a stop-loss at 86.25, as foreign portfolio investors (FPIs) continue to sell, analysts said. FPIs sold equities for teh second straight day, worth ₹3,548.92 crore, taking the total outflows in July to ₹5826 crore. Importers, meanwhile, may consider buying on dips for near-term cash requirements, Bhansali said. Rupee is expected to remain within a range of 85.75-86.60, according to Jateen Trivedi, VP research analyst - commodity and currency at LKP Securities. On the tariffs front, the US President Donald Trump announced a trade deal, imposing a 15 per cent tariff on Japanese exports to the US. The Trump administration had also reached an agreement with the Philippines setting a 19 per cent tariff on their exports. Equity and currency markets in the Asia region rose after the deal announcement. ALSO READ: Following this, the dollar index, a measure of the greenback against a basket of six major currencies, was up 0.05 per cent at 97.44. In commodities, crude oil prices were stable amid US-Japan trade deal optimism and crude oil inventory decline of the US. Brent crude price was up 0.31 per cent at 68.80 per barrel, while WTI crude prices were lower by 1.47 per cent at 66.21, as of 9:09 AM IST. ALSO READ:
&w=3840&q=100)

Business Standard
11 minutes ago
- Business Standard
M&M Financial share drops 3% on mixed Q1 nos; should you buy, sell or hold?
Mahindra & Mahindra Financial Services share price: Mahindra & Mahindra Financial Services share price was in focus on Wednesday, July 23, 2025, with the scrip dropping up to 2.93 per cent to an intraday low of 257.80 per share, nearing its 52-week low of 235.47. At 9:20 AM, Mahindra & Mahindra Financial Services share was trading 1.75 per cent lower at 260.95. In comparison, BSE Sensex was up 0.30 per cent at 82,429.66 levels M&M Financial Q1 results Mahindra & Mahindra Financial Services (MMFS) reported a modest 3 per cent year-on-year (Y-o-Y) rise in net profit to ₹530 crore for the quarter ended June 2025 (Q1FY26). However, on a sequential basis, net profit declined 6 per cent. Total income for the quarter increased 18 per cent Y-o-Y to ₹4,438 crore, while total expenses rose at a faster pace of 22 per cent to ₹3,744 crore. Net interest income (NII) grew 18 per cent Y-o-Y to ₹2,285 crore. However, credit costs spiked to ₹660 crore from ₹448 crore in the same period last year. Disbursements for the quarter came in at ₹12,808 crore, registering a 1 per cent Y-o-Y rise but falling 18 per cent sequentially. The company attributed the sequential dip to a slowdown in the underlying wheels business. The gross loan book expanded 15 per cent Y-o-Y to ₹1.22 trillion and grew 2 per cent quarter-on-quarter. Its MSME asset book grew 28 per cent Y-o-Y to ₹6,523 crore as of June 30, 2025, led by secured products like Loan Against Property (LAP), which now forms 44 per cent of total SME assets, up from 33 per cent last year. Stage 3 assets in this segment stood at 1.4 per cent, reflecting strong asset quality. Collection efficiency improved slightly to 95 per cent, up from 94 per cent in Q1FY25. Brokerages' view Motilal Oswal The company reported an operationally soft quarter with tepid disbursements and loan growth, according to analysts at Motilal Oswal. Asset quality weakened seasonally due to elevated credit costs, higher slippages, and persistent write-offs. On the positive side, net interest margin (NIM) expanded about 10 bps Q-o-Q, and management remains confident that NIM has bottomed out and is poised to improve. While loan growth and credit costs remain uncertain, a projected PAT CAGR of about 21 per cent over FY25–27 and RoA/RoE of 2.2 per cent/13 per cent in FY27E support a 'Buy' rating with a target price of ₹310 (1.6x Mar'27E BV). The M&M Financial stock is currently trading at 1.3x FY27E P/BV. Nuvama Those at Nuvama said, M&M Financial beat estimates on NII and pre-provision operating profit (PPOP), but missed on credit costs, which came in at 1.9 per cent – above the guided 1.5-1.7 per cent range. Still, given a tough operating environment and stable Stage 3 ECL at 51.4 per cent, the outcome is seen as acceptable. Disbursements remained weak (up 1 per cent Y-o-Y / down 18 per cent Q-o-Q). Reported spread improved 20 bps Q-o-Q, and PPOP rose 19 per cent Y-o-Y / 11 per cent Q-o-Q. PAT grew 3 per cent Y-o-Y but declined 6 per cent sequentially. Stage 2+3 ECL remained steady at 78.8 per cent versus 78.4 per cent Q-o-Q. Thus, analysts at Nuvama maintained a 'Hold' rating with a target price of ₹280 (1.6x FY26E BV), with growth momentum and credit cost normalisation as key monitorables.